Genetic engineering of novel animal virus vaccines

83241 Kit, S.; 2704 Animal Health Association, Richmond, Va. (EUA); 34092 90. Annual Meeting of the United States Animal Health Association Louisville, Ky. (EUA) 19-24 Oct 1986

Genetic engineering of novel animal virus vaccines

Conventional virus vaccines have numerous shortcomings. They are neither as safe as they ought to be, nor as efficacious. The shortcomings of conventional vaccines can be overcome through genetic engineering. The objectives of genetic engineering are to provide the producer and the practitioner with vaccines that are safer and more compatible with producer practices. The modified-live thymidine kinase deletion mutants of pseudorabies virus and infectious bovine rhinotracheitis virus provide examples of safe, efficacious, rationally designed, user friendly, veterinary vaccines. All vaccines, whether conventional or genetically engineered, ought to be evaluated by the same stringent standards, to insure their safety, purity, potency, and efficacy, and to verify that they do not have a negative environmental impact

Saved in:

Bibliographic Details
Main Authors:	83241 Kit, S., 2704 Animal Health Association, Richmond, Va. (EUA), 34092 90. Annual Meeting of the United States Animal Health Association Louisville, Ky. (EUA) 19-24 Oct 1986
Format:	biblioteca
Published:	Richmond, Va. (EUA) 1986
Subjects:	VACUNA, INGENIERIA GENETICA, VIROSIS, RECOMBINACION,
Tags:	Add Tag No Tags, Be the first to tag this record!

id	KOHA-OAI-BVE:41288
record_format	koha
spelling	KOHA-OAI-BVE:412882020-02-03T21:04:20ZGenetic engineering of novel animal virus vaccinesProceedings 83241 Kit, S. 2704 Animal Health Association, Richmond, Va. (EUA) 34092 90. Annual Meeting of the United States Animal Health Association Louisville, Ky. (EUA) 19-24 Oct 1986 Richmond, Va. (EUA)1986Conventional virus vaccines have numerous shortcomings. They are neither as safe as they ought to be, nor as efficacious. The shortcomings of conventional vaccines can be overcome through genetic engineering. The objectives of genetic engineering are to provide the producer and the practitioner with vaccines that are safer and more compatible with producer practices. The modified-live thymidine kinase deletion mutants of pseudorabies virus and infectious bovine rhinotracheitis virus provide examples of safe, efficacious, rationally designed, user friendly, veterinary vaccines. All vaccines, whether conventional or genetically engineered, ought to be evaluated by the same stringent standards, to insure their safety, purity, potency, and efficacy, and to verify that they do not have a negative environmental impactConventional virus vaccines have numerous shortcomings. They are neither as safe as they ought to be, nor as efficacious. The shortcomings of conventional vaccines can be overcome through genetic engineering. The objectives of genetic engineering are to provide the producer and the practitioner with vaccines that are safer and more compatible with producer practices. The modified-live thymidine kinase deletion mutants of pseudorabies virus and infectious bovine rhinotracheitis virus provide examples of safe, efficacious, rationally designed, user friendly, veterinary vaccines. All vaccines, whether conventional or genetically engineered, ought to be evaluated by the same stringent standards, to insure their safety, purity, potency, and efficacy, and to verify that they do not have a negative environmental impactVACUNAINGENIERIA GENETICAVIROSISRECOMBINACION
institution	IICA
collection	Koha
country	Costa Rica
countrycode	CR
component	Bibliográfico
access	En linea
databasecode	cat-sibiica
tag	biblioteca
region	America Central
libraryname	Sistema de Bibliotecas IICA/CATIE
topic	VACUNA INGENIERIA GENETICA VIROSIS RECOMBINACION VACUNA INGENIERIA GENETICA VIROSIS RECOMBINACION
spellingShingle	VACUNA INGENIERIA GENETICA VIROSIS RECOMBINACION VACUNA INGENIERIA GENETICA VIROSIS RECOMBINACION 83241 Kit, S. 2704 Animal Health Association, Richmond, Va. (EUA) 34092 90. Annual Meeting of the United States Animal Health Association Louisville, Ky. (EUA) 19-24 Oct 1986 Genetic engineering of novel animal virus vaccines
description	Conventional virus vaccines have numerous shortcomings. They are neither as safe as they ought to be, nor as efficacious. The shortcomings of conventional vaccines can be overcome through genetic engineering. The objectives of genetic engineering are to provide the producer and the practitioner with vaccines that are safer and more compatible with producer practices. The modified-live thymidine kinase deletion mutants of pseudorabies virus and infectious bovine rhinotracheitis virus provide examples of safe, efficacious, rationally designed, user friendly, veterinary vaccines. All vaccines, whether conventional or genetically engineered, ought to be evaluated by the same stringent standards, to insure their safety, purity, potency, and efficacy, and to verify that they do not have a negative environmental impact
format
topic_facet	VACUNA INGENIERIA GENETICA VIROSIS RECOMBINACION
author	83241 Kit, S. 2704 Animal Health Association, Richmond, Va. (EUA) 34092 90. Annual Meeting of the United States Animal Health Association Louisville, Ky. (EUA) 19-24 Oct 1986
author_facet	83241 Kit, S. 2704 Animal Health Association, Richmond, Va. (EUA) 34092 90. Annual Meeting of the United States Animal Health Association Louisville, Ky. (EUA) 19-24 Oct 1986
author_sort	83241 Kit, S.
title	Genetic engineering of novel animal virus vaccines
title_short	Genetic engineering of novel animal virus vaccines
title_full	Genetic engineering of novel animal virus vaccines
title_fullStr	Genetic engineering of novel animal virus vaccines
title_full_unstemmed	Genetic engineering of novel animal virus vaccines
title_sort	genetic engineering of novel animal virus vaccines
publisher	Richmond, Va. (EUA)
publishDate	1986
work_keys_str_mv	AT 83241kits geneticengineeringofnovelanimalvirusvaccines AT 2704animalhealthassociationrichmondvaeua geneticengineeringofnovelanimalvirusvaccines AT 3409290annualmeetingoftheunitedstatesanimalhealthassociationlouisvillekyeua1924oct1986 geneticengineeringofnovelanimalvirusvaccines AT 83241kits proceedings AT 2704animalhealthassociationrichmondvaeua proceedings AT 3409290annualmeetingoftheunitedstatesanimalhealthassociationlouisvillekyeua1924oct1986 proceedings
_version_	1756053424465510400

Genetic engineering of novel animal virus vaccines

Similar Items

Resource Map